Sponsors

Genomic Healthcare Strategies is a consulting group for a new era—the era of molecular medicine. The emergent understanding of the molecular basis of disease is transforming the practice of medicine, producing a new generation of diagnostics and pharmaceuticals that are effecting changes in research, development and clinical trials. It is also beginning to influence the way products are regulated, institutions provide services, payors reimburse for services, and physicians address individual patients. Molecular medicine has the potential to improve the quality of care for individual patients and thus will profoundly affect the patient-physician relationship.

The new era demands new business strategies. Traditional 20th-century approaches, which segregate research, development, marketing, communications, and physician and patient education, are not up to the challenges of the rapidly evolving marketplace. To succeed in this uncharted territory requires an integrated multidisciplinary approach.

GHS takes just that approach. The members of our team are senior executives, physicians, economists, and policy-makers with successful track records in medicine, academia, regulatory agencies, and industry. We can supply the operational, strategic, scientific, and financial expertise to take your project, whether the launch of a product, a service, or a new company, from conception to success in the marketplace.

Nixon Peabody LLP is one of the largest law firms in the United States. With 700 attorneys collaborating across 25 major practice areas in 17 office locations, including Boston, Chicago, New York City, Rochester, San Francisco, Silicon Valley, and Washington, DC, the firm’s size, diversity, and advanced technological resources enable it to offer comprehensive legal services to individuals and organizations of all sizes in local, state, national, and international matters. Nixon Peabody has been recognized by FORTUNE magazine as one of the “100 Best Companies To Work For®” in 2007 for the second consecutive year. The firm was also recognized as a “Best Place to Work” by the Boston Business Journal for 2007 and has been named to the Human Rights Campaign Foundation’s 2007 “Best Places To Work For GLBT Equality” list.

With support from...

The Personalized Medicine Coalition (PMC) is an independent, nonprofit group that works to advance the understanding and adoption of personalized medicine for the ultimate benefit of patients. Our diverse members work together to educate opinion leaders and the public about the issues that will shape how personalized medicine develops— and how quickly all of us can benefit from it.

The PMC educates federal and state policymakers and private sector health care leaders about personalized medicine, helping them understand the science, the issues, and what is needed for the positive evolution of personalized medicine.

The PMC has four key goals:

Provide opinion leadership on public policy issues that affect personalized medicine
Help educate the public, policymakers, government officials, and private sector health care leaders about the public and personal health benefits of personalized medicine
Serve as a forum for identifying and informing others of those public policies that may impede the ability to deliver the promise of personalized medicine
Create a structure for achieving consensus positions on crucial public policy issues and supporting changes needed to further the public interest in personalized medicine

The PMC works closely with existing organizations to improve the understanding of personalized medicine and related issues, in a way that avoids duplication of efforts and leverages their activities.